Thursday, August 27, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
Devices & TechAlma Lasers Unveils Harmony PlatformtodayBusiness & M&AAllergan Aesthetics Overhauls Loyalty Program3 days agoDevices & TechNew Tool for Sagging Skin Gains Practitioner TractiontodayRegulatoryAbbVie Launches Phase 2 Forehead Lines Study3 days agoBusiness & M&AEvolus Q2 Revenue Beats Forecast, Raises 2026 OutlookyesterdayDevices & TechXERF Technology Launches in Sydney for Skin Tightening2 days agoBusiness & M&ASisram Medical H1 2026: APAC Growth Offsets Margin PressureyesterdayDevices & TechMerz Partners with NANOTEC on Aesthetic Longevity2 days agoDevices & TechInMode Consolidates Between Support and Resistance LevelsyesterdayBusiness & M&AGalderma Opens Miami HQ for U.S. and Latin America2 days agoDevices & TechClassys Global Device Sales to Surpass 50,000 Units in 2026yesterdayInjectablesRHA Redensity Eye Wins FDA Nod for Under-Eye Hollows2 days ago
1 free article left this week. A free account gets you 4 a week.Go Pro →
Market

InMode Guides Q2 2026 Revenue to $95.2M–$95.4M; Full-Year Outlook Holds at $365M–$375M

Device maker reiterates FY guidance despite takeover bid uncertainty; Q2 results due August 5.

Image: Inside MedSpa
1-YEAR MOVE
+3% −14%
INMD ▲1.0%
1-year price move by ticker
TickerCompany1-year change
INMDInMode Ltd.+1.0%

InMode has provided Q2 2026 revenue guidance of $95.2 million to $95.4 million and reiterated full-year 2026 revenue guidance of $365 million to $375 million, signaling operational confidence amid the Steel Partners acquisition bid. The guidance suggests mid-single-digit year-over-year growth, consistent with the company's historical trajectory in a market where RF device adoption remains steady but competitive intensity is rising.

InMode guides FY 2026 revenue to $365M–$375M despite takeover bid.

The reaffirmed outlook indicates InMode's board is not materially adjusting business expectations in response to takeover activity—a typical posture during M&A processes. For practice owners evaluating device capital allocation, the guidance provides a baseline for assessing InMode's competitive durability and whether a change-of-control event might alter service, support, or pricing terms post-close.

Source: original report ↗

Frequently asked questions

What is InMode's revenue guidance for Q2 2026?

InMode guided Q2 2026 revenue between $95.2 million and $95.4 million, representing mid-single-digit year-over-year growth. The company reaffirmed this guidance despite ongoing Steel Partners acquisition bid uncertainty.

What is InMode's full-year 2026 revenue outlook?

InMode maintained full-year 2026 revenue guidance of $365 million to $375 million. This reiterated guidance signals the board is maintaining operational confidence and not materially adjusting expectations due to M&A activity.

Should med spa owners be concerned about InMode's acquisition by Steel Partners?

The reaffirmed guidance suggests InMode's board is confident in business fundamentals despite takeover activity. Practice owners should monitor whether a change-of-control event might alter service, support, or pricing terms post-close, but current guidance indicates stable operations.

Is RF device adoption slowing in the aesthetic market?

InMode's mid-single-digit growth guidance reflects steady RF device adoption, though competitive intensity in the market is rising. The guidance suggests the RF device market remains stable but increasingly competitive.

When will InMode report Q2 2026 results?

InMode's Q2 2026 results are scheduled for release on August 5. This will provide actual performance data against the $95.2M–$95.4M guidance range.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $20/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://insidemedspa.com/article/inmode-q2-2026-revenue-guidance/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa Pro

    By the time it's news, it's too late.

    The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

    Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
    The twice-a-week intelligence brief Go Pro · $20/mo